Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol SHOX contributors: mct/pgu - updated : 30-11-2011
HGNC name short stature homeobox
HGNC id 10853
EXPRESSION
Type widely
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Cardiovascularheart    
Endocrinepancreas    
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Blood / Hematopoieticbone marrow   
Connectivebone   
Muscularstriatumskeletal  
cell lineage
cell lines
fluid/secretion
at STAGE
physiological period embryo, pregnancy
Text
  • placenta, pharyngeal pouches, limbs
  • expressed both in early embryonic limb development and in fetal and childhood growth plates
  • coexpression of SHOX, SOX5, SOX6 and SOX9 in the fetal growth plate
  • PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
  • DNA binding protein with POU specific and POU homeo (helix-turn-helix) domains
  • the C terminal OAR domain found in homeo domain proteins highly expressed in craniofacial tissues
  • HOMOLOGY
    interspecies homolog to murine OG-12a,OG-12b
    intraspecies homolog to SHOX2
    Homologene
    FAMILY
  • paired homeobox family
  • bicoid subfamily
  • CATEGORY DNA associated , transcription factor
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,nucleus
    basic FUNCTION
  • transcriptional activator
  • cell specific involved in the limb development and first and second pharyngeal arches
  • playing a role in chondrocyte function in the growth plate
  • plays a direct role in regulating the differentiation of hypertrophic/apoptotic chondrocytes of the growth plate
  • transcription factor which is important for normal limb development
  • cooperates with SOX5/SOX6 and SOX9 in the activation of the upstream ACAN enhancer
  • SHOX appears to be critical for normal pacemaking function
  • plays a similar role as SHOX2 in the sinoatrial node formation and pacemaking function by controlling a genetic cascade through the repression of NKX2-5
  • CELLULAR PROCESS nucleotide, transcription, regulation
    PHYSIOLOGICAL PROCESS development
    text organogenesis
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA binding
    RNA
    small molecule
    protein
  • FGFR3 is a novel transcriptional target of SHOX (SHOX strongly activate the extended FGFR3 promoter)
  • cooperates with SOX5/SOX6 and SOX9 in the activation of the upstream ACAN enhancer
  • cell & other
    REGULATION
    Other regulated by a combination of transcriptional and translational control mechanisms
    ASSOCIATED DISORDERS
    corresponding disease(s) DCS , GCX , MMDL , SHSIX , DELXPF , DELXPM
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional     --over  
    in structural and numerical X abnormalities
    constitutional   deletion    
    in idiopathic short stature (hot-spot of proximal deletion )
    constitutional   amplification    
    duplication with a variable amount of flanking sequence and unclear clinical significance
    constitutional       loss of function
    would create a relatively increased FGFR3 expression in ulna and radius as well as in tibia and fibula, thereby accelerating a fusion of the growth plates and causing a relative shortening of the respective bones
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS